169 related articles for article (PubMed ID: 9787988)
1. Pharmacologic profile of tazarotene.
Duvic M
Cutis; 1998 Feb; 61(2 Suppl):22-6. PubMed ID: 9787988
[TBL] [Abstract][Full Text] [Related]
2. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
[TBL] [Abstract][Full Text] [Related]
3. Clinical safety of tazarotene in the treatment of plaque psoriasis.
Marks R
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S25-32. PubMed ID: 9270553
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
Tang-Liu DD; Matsumoto RM; Usansky JI
Clin Pharmacokinet; 1999 Oct; 37(4):273-87. PubMed ID: 10554045
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of tazarotene action in psoriasis.
Duvic M; Nagpal S; Asano AT; Chandraratna RA
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of tazarotene: optimizing clinical results.
Lebwohl M
Cutis; 1998 Feb; 61(2 Suppl):27-9. PubMed ID: 9787989
[TBL] [Abstract][Full Text] [Related]
7. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
8. Receptor-selective retinoids for psoriasis: focus on tazarotene.
Weindl G; Roeder A; Schäfer-Korting M; Schaller M; Korting HC
Am J Clin Dermatol; 2006; 7(2):85-97. PubMed ID: 16605289
[TBL] [Abstract][Full Text] [Related]
9. In vitro compatibility of tazarotene with other topical treatments of psoriasis.
Hecker D; Worsley J; Yueh G; Lebwohl M
J Am Acad Dermatol; 2000 Jun; 42(6):1008-11. PubMed ID: 10827404
[TBL] [Abstract][Full Text] [Related]
10. The role of tazarotene in the treatment of psoriasis.
Marks R
Br J Dermatol; 1999 Apr; 140 Suppl 54():24-8. PubMed ID: 10731131
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study.
Huang YC; Chou CL; Chiang YY
Lasers Surg Med; 2013 Feb; 45(2):102-7. PubMed ID: 23423871
[TBL] [Abstract][Full Text] [Related]
12. Tazarotene gel: efficacy and safety in plaque psoriasis.
Weinstein GD
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S33-8. PubMed ID: 9270554
[TBL] [Abstract][Full Text] [Related]
13. Topical tazarotene therapy for psoriasis, acne vulgaris, and photoaging.
Guenther LC
Skin Therapy Lett; 2002 Mar; 7(3):1-4. PubMed ID: 12007011
[TBL] [Abstract][Full Text] [Related]
14. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
Weinstein GD; Koo JY; Krueger GG; Lebwohl MG; Lowe NJ; Menter MA; Lew-Kaya DA; Sefton J; Gibson JR; Walker PS;
J Am Acad Dermatol; 2003 May; 48(5):760-7. PubMed ID: 12734506
[TBL] [Abstract][Full Text] [Related]
15. Periungual pyogenic granulomas due to topical tazarotene for nail psoriasis.
Piraccini BM; Venturi M; Patrizi A
G Ital Dermatol Venereol; 2014 Jun; 149(3):363-6. PubMed ID: 24819765
[TBL] [Abstract][Full Text] [Related]
16. An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid.
Tanghetti EA;
Cutis; 2000 Dec; 66(6 Suppl):4-11. PubMed ID: 11147088
[TBL] [Abstract][Full Text] [Related]
17. Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging.
Roeder A; Schaller M; Schäfer-Korting M; Korting HC
Skin Pharmacol Physiol; 2004; 17(3):111-8. PubMed ID: 15087589
[TBL] [Abstract][Full Text] [Related]
18. Tazarotene--first of a new generation of receptor-selective retinoids.
Chandraratna RA
Br J Dermatol; 1996 Oct; 135 Suppl 49():18-25. PubMed ID: 9035701
[TBL] [Abstract][Full Text] [Related]
19. A pharmacoeconomic analysis of topical therapies for patients with mild-to-moderate stable plaque psoriasis: a US study.
Marchetti A; LaPensee K; An P
Clin Ther; 1998; 20(4):851-69. PubMed ID: 9737842
[TBL] [Abstract][Full Text] [Related]
20. Tazarotene.
Foster RH; Brogden RN; Benfield P
Drugs; 1998 May; 55(5):705-11; discussion 712. PubMed ID: 9585866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]